{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:40:38Z","timestamp":1790786438258,"version":"4.1.0"},"reference-count":25,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2020,3,1]]},"DOI":"10.1001\/jamainternmed.2019.6447","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T11:00:56Z","timestamp":1578913256000},"page":"420","source":"Crossref","is-referenced-by-count":109,"title":["Association of Ticagrelor vs Clopidogrel With Major Adverse Coronary Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention"],"prefix":"10.1001","volume":"180","author":[{"given":"Ricky D.","family":"Turgeon","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Vancouver General Hospital, Vancouver, British Columbia, Canada"},{"name":"Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheri L.","family":"Koshman","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Youngson","sequence":"additional","affiliation":[{"name":"Alberta SPOR Support Unit, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Har","sequence":"additional","affiliation":[{"name":"Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Wilton","sequence":"additional","affiliation":[{"name":"Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"James","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Graham","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"ioi190107r1","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cjca.2017.12.012","article-title":"2018 Canadian Cardiovascular Society\/Canadian Association of Interventional Cardiology focused update of the guidelines for the use of antiplatelet therapy.","volume":"34","author":"Mehta","year":"2018","journal-title":"Can J Cardiol"},{"issue":"10","key":"ioi190107r2","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1161\/CIR.0000000000000404","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines: an update of the 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention, 2011 ACCF\/AHA guideline for coronary artery bypass graft surgery, 2012 ACC\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction, 2014 AHA\/ACC guideline for the management of patients with non\u2013ST-elevation acute coronary syndromes, and 2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery.","volume":"134","author":"Levine","year":"2016","journal-title":"Circulation"},{"issue":"11","key":"ioi190107r3","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes.","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"issue":"23","key":"ioi190107r4","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1093\/eurheartj\/ehr231","article-title":"Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes.","volume":"32","author":"Storey","year":"2011","journal-title":"Eur Heart J"},{"issue":"3","key":"ioi190107r5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jacc.2010.01.062","article-title":"Incidence of dyspnea and assessment of cardiac and pulmonary function in patients with stable coronary artery disease receiving ticagrelor, clopidogrel, or placebo in the ONSET\/OFFSET study.","volume":"56","author":"Storey","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"ioi190107r6","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction.","volume":"372","author":"Bonaca","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"ioi190107r7","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1186\/s13063-015-1023-4","article-title":"A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results.","volume":"16","author":"Kennedy-Martin","year":"2015","journal-title":"Trials"},{"issue":"8","key":"ioi190107r8","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1001\/jama.2014.6217","article-title":"Clinical trial participation after myocardial infarction in a national cardiovascular data registry.","volume":"312","author":"Udell","year":"2014","journal-title":"JAMA"},{"issue":"10","key":"ioi190107r9","first-page":"1225","article-title":"Overview of the Alberta provincial project for outcome assessment in coronary heart disease: on behalf of the APPROACH investigators.","volume":"16","author":"Ghali","year":"2000","journal-title":"Can J Cardiol"},{"issue":"7-8","key":"ioi190107r10","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1345\/aph.1H018","article-title":"Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures.","volume":"40","author":"Hess","year":"2006","journal-title":"Ann Pharmacother"},{"issue":"8","key":"ioi190107r11","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/(ISSN)1099-1557","article-title":"Methods for evaluation of medication adherence and persistence using automated databases.","volume":"15","author":"Andrade","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"ioi190107r12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1001\/jama.297.2.177","article-title":"Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction.","volume":"297","author":"Rasmussen","year":"2007","journal-title":"JAMA"},{"issue":"3","key":"ioi190107r13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092286","article-title":"Validity of myocardial infarction diagnoses in administrative databases: a systematic review.","volume":"9","author":"McCormick","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"ioi190107r14","doi-asserted-by":"publisher","first-page":"E121","DOI":"10.1503\/cmaj.121218","article-title":"Rates of hemorrhage during warfarin therapy for atrial fibrillation.","volume":"185","author":"Gomes","year":"2013","journal-title":"CMAJ"},{"issue":"2","key":"ioi190107r15","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.thromres.2005.06.015","article-title":"Accuracy of coding for possible warfarin complications in hospital discharge abstracts.","volume":"118","author":"Arnason","year":"2006","journal-title":"Thromb Res"},{"issue":"11","key":"ioi190107r16","doi-asserted-by":"publisher","first-page":"E299","DOI":"10.1503\/cmaj.181186","article-title":"A disease-specific comorbidity index for predicting mortality in patients admitted to hospital with a cardiac condition.","volume":"191","author":"Azzalini","year":"2019","journal-title":"CMAJ"},{"issue":"4","key":"ioi190107r17","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.115.019861","article-title":"Atherothrombotic risk stratification and the efficacy and safety of vorapaxar in patients with stable ischemic heart disease and previous myocardial infarction.","volume":"134","author":"Bohula","year":"2016","journal-title":"Circulation"},{"issue":"44","key":"ioi190107r18","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1093\/eurheartj\/ehw284","article-title":"Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry.","volume":"37","author":"Sahl\u00e9n","year":"2016","journal-title":"Eur Heart J"},{"issue":"9824","key":"ioi190107r19","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/S0140-6736(12)60324-9","article-title":"Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.","volume":"379","author":"Palmerini","year":"2012","journal-title":"Lancet"},{"issue":"10","key":"ioi190107r20","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.4244\/EIJ-D-17-00634","article-title":"Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT.","volume":"13","author":"Zocca","year":"2017","journal-title":"EuroIntervention"},{"issue":"16","key":"ioi190107r21","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1056\/NEJMoa1908973","article-title":"Ticagrelor or prasugrel in patients with acute coronary syndromes.","volume":"381","author":"Sch\u00fcpke","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"ioi190107r22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ijcard.2014.02.028","article-title":"Effect of ticagrelor-related dyspnea on compliance with therapy in acute coronary syndrome patients.","volume":"173","author":"Gaubert","year":"2014","journal-title":"Int J Cardiol"},{"issue":"24","key":"ioi190107r23","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1161\/CIRCULATIONAHA.106.618066","article-title":"Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry.","volume":"113","author":"Spertus","year":"2006","journal-title":"Circulation"},{"issue":"7","key":"ioi190107r24","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1161\/CIRCULATIONAHA.106.686048","article-title":"Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment.","volume":"116","author":"Airoldi","year":"2007","journal-title":"Circulation"},{"issue":"8","key":"ioi190107r25","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/clc.2014.37.issue-8","article-title":"Adherence to dual antiplatelet therapy after coronary stenting: a systematic review.","volume":"37","author":"Czarny","year":"2014","journal-title":"Clin Cardiol"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2758798\/jamainternal_turgeon_2020_oi_190107.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T11:01:07Z","timestamp":1583146867000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2758798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2019.6447","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,1]]}}}